Actively Recruiting
University of Kansas Medical Center Biobank for Interstitial and Rare Lung Diseases
Led by University of Kansas Medical Center · Updated on 2026-07-10
1000
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are developing a registry and biorepository for Interstitial Lung Disease ILD and Rare Lung Diseases RLD to improve understanding of these conditions. The study aims to identify new methods for early diagnosis, uncover genetic and environmental risk factors, and find potential treatment targets by collecting patient information and biological samples. This observational study is led by the University of Kansas Medical Center and involves patients seen at their ILD and Rare Lung Disease clinic. Participants include patients with ILD, RLD, or those at risk for these diseases seen at the University of Kansas Health System or enrolled in approved studies. The study collects clinical data, biological samples, and historical information including imaging from deceased patients. These samples and data are made available to researchers studying ILD and RLD. There is no investigational treatment the focus is on data and specimen collection to support research. During the study, participants provide consent and their clinical information and biological samples are collected and correlated over time. Researchers will track data and samples for up to ten years to support ongoing and future research. This includes clinical data collection, sample storage, and providing materials for scientific studies. Participation involves no direct treatment but contributes to advancing knowledge in ILD and RLD.
CONDITIONS
Brief Title
Interstitial Lung Disease Research Unit Biobank
Research Team
K
Kimberly Donnelly, Ph.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here